By linking metabolic tumor characteristics with Cone Beam CT imaging, Jeff Geschwind advances highly selective TACE procedures. His work boosts intraprocedural decision-making, increases treatment accuracy, and strengthens clinical outcomes for hepatocellular carcinoma. https://about.me/jeff.geschwind